Hereditary hearing loss affects tens of millions globally, yet a significant fraction of cases still lack a genetic explanation. Identifying new causal genes not only expands diagnostic capacity but illuminates the precise cellular machinery the inner ear depends on — and this new finding points squarely at the cytoskeleton as a critical, underappreciated target.
In a study published in PNAS, researchers traced bilateral, moderate, congenital hearing loss in an extended Palestinian family to a homozygous splice-site mutation in FMN1 — the gene encoding formin-1, the founding member of the formin protein family, which had paradoxically never before been linked to a human disease phenotype. The variant (c.2162-2A>G) triggers aberrant splicing and nonsense-mediated decay, eliminating detectable formin-1 protein. Parallel investigation of the Fmn1Pro/Pro knockout mouse replicated the human auditory phenotype and revealed the structural basis: cochlear supporting cells — specifically Deiters' and pillar cells — exhibited profound disorganization of their normally tightly bundled microtubule networks. These structural abnormalities appeared early postnatally and persisted. Functionally, auditory brainstem response recordings showed reduced wave I amplitudes, indicating diminished auditory nerve activity, consistent with a reduced number of auditory nerve fibers.
The finding is notable for several reasons beyond simply adding FMN1 to the hereditary hearing loss gene list. Formins are best known as actin-nucleating proteins, yet this work highlights formin-1's role in microtubule organization specifically within non-sensory supporting cells — a cellular population that has gained increasing recognition for its biomechanical contribution to organ of Corti function. This positions FMN1-related hearing loss within a broader emerging paradigm: that cytoskeletal integrity in supporting cells, not just hair cell survival, is essential for cochlear mechanics and auditory nerve maintenance. The human phenotype — stable, moderate, bilateral loss with associated light hair pigmentation but no syndromic features — provides a relatively clean clinical signature that may aid future genetic diagnosis. Key limitations include the single-family human dataset and the inherent challenges of extrapolating mouse cochlear biology to human timescales, but the mechanistic convergence across species strengthens the causal interpretation considerably.